Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate Cancer

In Grade group 2-4 prostate cancer, total Gleason pattern 4 length for the case is a stronger predictor of adverse pathologic stage and biochemical recurrence than Grade group and other standard clinical variables. Further research is warranted to determine the optimal method for quantifying pattern 4 before incorporation into risk stratification algorithms.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-03-02
DOI
https://doi.org/10.64898/2026.02.27.26347289
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate Cancer

Melissa J. Assel, Nate Aiken, Samson W Fine, Reuter Ve et al.
medRxiv
Prostate Cancer Diagnosis and Treatment
article

Total Gleason Pattern 4 Length Outperforms Grade Group and Clinical Models in Predicting Oncologic Outcomes in Grade Group 2-4 Prostate Cancer

Melissa J. Assel, Nate Aiken, Samson W Fine, Reuter Ve, Behfar Ehdaie, Nicole Liso, Andrew J Vickers, Sean A. Fletcher, Nicholas Alexander Pickersgill
article en

Abstract

In Grade group 2-4 prostate cancer, total Gleason pattern 4 length for the case is a stronger predictor of adverse pathologic stage and biochemical recurrence than Grade group and other standard clinical variables. Further research is warranted to determine the optimal method for quantifying pattern 4 before incorporation into risk stratification algorithms.

medRxiv
Memorial Sloan Kettering Cancer Center (US)
Memorial Sloan-Kettering Cancer Center, OPKO Health, National Institutes of Health, Sidney Kimmel Center for Prostate and Urologic Cancers, National Cancer Institute
Peace, Justice and strong institutions, Reduced inequalities
Openalex Percentile: Top 36%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.